SOPAT is on the road: CPhI, Delhi India

  • Spalte bearbeiten
  • Spalte duplizieren
  • Spalte hinzufügen
  • Spalte löschen
 
 

From 12 to 14 December 2018 the congress CPhI will take place in Delhi, India.

Especially for the pharmaceutical industry, India is becoming more and more attractive to obtain high-quality and cost-effective pharmaceutical solutions. CPhI & P-MEC India are therefore the ideal events for companies that want to pick up on the latest trends and innovations in the market. At these events, SOPAT will be represented by its Indian sales partner Spinco Biotech Ltd. (Hall 15 D19), with the support of SOPAT’s founder and CEO, Dr. Sebastian Maaß.

Cutting Edge: The Importance of Particle Size Analysis

In December’s issue of Spinco Biotech’s Cutting Edge magazine, SOPAT’s founder and CEO Dr. Sebastian Maaß talks about the importance of particle size analysis in the pharmaceutical industry.

In the five-page article, the importance of the particle size is highlighted as an important attribute in APIs, solid oral drug products (tablets and capsules – impacting on homogeneity, flow and processing), and as a critical quality attribute in semi-solids (suspensions) and sterile liquid products (injectables).

The full article can be downloaded here.